Company profile for Minovia Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We strive to be the global leader in developing novel Mitochondrial Cell Therapies to treat people stricken with mitochondrial diseases. Every day, together with the world’s leading scientists, clinicians and patients’ groups we are translating our mitochondrial science into meaningful therapies for mitochondrial diseases – anywhere from ultra-rare to more common ones.Our ability to execute is driven by our highly exper...
We strive to be the global leader in developing novel Mitochondrial Cell Therapies to treat people stricken with mitochondrial diseases. Every day, together with the world’s leading scientists, clinicians and patients’ groups we are translating our mitochondrial science into meaningful therapies for mitochondrial diseases – anywhere from ultra-rare to more common ones.Our ability to execute is driven by our highly experienced executive team, comprehensive regulatory strategy and clinical development plan in partnerships with key physicians and advisors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
Tirat Carmel, Hefa
Telephone
Telephone
+972-747039954
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/20/3191904/0/en/Minovia-Therapeutics-Mitochondrial-Augmentation-Technology-to-be-Featured-in-Presentation-and-Workshop-at-the-67th-ASH-Annual-Meeting-and-Exposition.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/10/15/3166960/0/en/Minovia-Therapeutics-Receives-FDA-Orphan-Drug-Designation-for-MNV-201-in-Myelodysplastic-Syndrome.html

GLOBENEWSWIRE
15 Oct 2025

https://www.globenewswire.com/news-release/2025/09/18/3152312/0/en/Minovia-Therapeutics-Receives-FDA-Fast-Track-Designation-for-MNV-201-in-Myelodysplastic-Syndrome.html

GLOBENEWSWIRE
18 Sep 2025

https://www.globenewswire.com/news-release/2025/08/27/3139893/0/en/Minovia-Therapeutics-Announces-350-000-Grant-from-Countdown-for-a-Cure-Foundation-to-Develop-Mitochondria-Blood-Based-Biomarkers.html

GLOBENEWSWIRE
27 Aug 2025

https://www.fiercebiotech.com/biotech/minovia-brings-back-spac-plans-skate-icy-public-market

FIERCE BIOTECH
24 Jun 2025

https://www.globenewswire.com/news-release/2025/04/03/3055005/0/en/Minovia-Therapeutics-Announces-FDA-Clearance-of-Second-IND-Application-for-a-Phase-II-Clinical-Trial-of-Lead-Product-MNV-201-in-Pearson-Syndrome.html

GLOBENEWSWIRE
03 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty